Please wait
HEALTHCARE · Pharmaceutical Preparations · Price, fundamentals, signals, and forward-looking context in one research view.
HEALTHCARE
₦69B
1.0%
12.66
Current price
₦40.00
Updated Updated 2h ago
Open
N/A
Previous close
₦40.00
Day range
N/A
Volume
118,247
12.7x P/E
Awaiting filing
1.0% yield
65/100 measured
Moderate liquidity
The latest saved price history for MAYBAKER, with its range and direction at a glance.
Eye extracted 42 pages. Open the source or continue to Signals for the evidence trail.
May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name. In addition, the company engages in contract manufacturing of pharmaceutical products; and in healthcare and industrial packaging. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.
Investors usually follow MAYBAKER for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Director dealings
0
Reported buys, sells, and mixed dealings.
Official filings
12
Financial reports and company disclosures captured by Eye.
Market events
0
Insider, filing, dividend, and price events.
Source records
43
Captured updates we can trace.
Whisone is bullish because fundamentals are solid at 80/100 while today's volume is only 21% of average. Whisone has high conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
39.9%
Return on equity
ROA
16.8%
Return on assets
Debt / equity
0.18
Lower is usually safer.
P/B ratio
4.32
Useful for book value support.
Dividend yield
1.0%
Current income signal.
77/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price behavior and momentum still support follow-through.
Trading liquidity looks supportive for the forecast to transmit into price action.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
₦39.98
Analyst view
n/a
Forecast refresh
Updated 5h ago
Quality score
80
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
53.1
Momentum is currently in a neutral range.
Recent trend
Sideways
+0.0% across the latest saved price window.
Volatility
Low
Beta is 0.67. Price has historically moved more calmly than the wider market.
52-week position
66% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
0.21x average
Trading activity is light, so the current price move has weaker confirmation.
The article notes Nigeria's pharmaceutical firms are investing in local manufacturing and import substitution to reduce dependence on foreign supply, a trend that supports domestic pharma firms' growth and access.
local_manufacturing_and_access
MAYBAKER may also move because the HEALTHCARE sector may benefit from local_manufacturing_and_access. Confidence 56%.
MeCure's emphasis on affordable, locally manufactured medicines and wider market penetration illustrates sector-level support for improved local manufacturing and access to quality medicines.
manufacturing infrastructure
MAYBAKER may also move because the HEALTHCARE sector may benefit from manufacturing infrastructure. Confidence 56%.
Completion of a pharmaceutical manufacturing facility by Neimeth increases manufacturing capacity in the healthcare sector.
local_manufacturing_and_product_innovation
MAYBAKER may also move because the HEALTHCARE sector may move with local_manufacturing_and_product_innovation. Confidence 53%.
MeCure's focus on deepening local manufacturing, product innovation, and expanded market penetration reflects sector-wide themes of local production and access to affordable medicines.
profit-taking
MAYBAKER may also move because the HEALTHCARE sector may move with profit-taking. Confidence 53%.
Profit-taking is identified in the article as a trigger for the sell-off impacting SWOOT stocks.
increased manufacturing capacity
MAYBAKER may also move because the HEALTHCARE sector may benefit from increased manufacturing capacity. Confidence 53%.
Neimeth's expansion and completion of a pharmaceutical manufacturing facility will increase production capacity within the healthcare sector.
Halal certification adoption
MAYBAKER may also move because the HEALTHCARE sector may benefit from halal certification adoption. Confidence 49%.
Halal certification can increase consumer confidence and market access where Halal-compliant products are important, supporting sector trust and accessibility.
MAYBAKER
May & Baker Nigeria Plc
Price: ₦40.00
P/E: 12.66
Yield: 1.0%
EKOCORP
Eko Corporation Plc
Price: ₦5.80
P/E: N/A
Yield: N/A
FIDSON
Fidson Healthcare Plc
Price: ₦93.55
P/E: 22.27
Yield: 1.6%
MECURE
MeCure Industries Plc
Price: ₦56.20
P/E: 31.18
Yield: 0.6%
Industry
Pharmaceutical Preparations
Founded
1944
Employees
414
Exchange
NGX
Ticker
MAYBAKER
2026-07-29
Estimated earnings date
2026-07-27
Ex-dividend date
2026-05-20
